MedTrace Logo

Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia

NCT00273676 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2006-01-09

No results posted yet for this study

Summary

Patients with severe community-acquired pneumonia are included Half of the patients are treated with a 3 day course of intravenous antibiotics, followed, when clinical stable, by a course of oral antibiotics. Efficacy of this treatment is compared to a standard course of 7 days of intravenous antibiotics, which treatment is assigned to the other half of patients. Outcomes measured are clinical cure and costs.

Conditions

  • Severe Communtity-Acquired Pneumonia

Interventions

PROCEDURE

Conversion to oral antibiotic treatment after 3 days of intravenous antibiotic treatment

Sponsors & Collaborators

  • Dutch Health Care Insurance Board

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Andy IM Hoepelman, Professor of Medicine · University Medical Center, Department of Internal Medicine and Infectious Diseases, Utrecht, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-07-31
Completion
2004-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273676 on ClinicalTrials.gov